The present study demonstrates that DSS alleviates cognitive deficits in APP/PS1 mice by modulating the AMPK/Sp1/ACSL4 signalling axis to inhibit neuronal ferroptosis, providing a novel therapeutic strategy for AD. Here, ACSL4 is linked to Alzheimer disease.